
DHL Supply Chain boosts its US life sciences investment by $70 million
More warehouse capacity, plus a growing investment in robotics
Having
One of the drivers of the current round of expansion, says David Kopstein, VP of Life Sciences & Healthcare, DHL Supply Chain North America, is that manufacturers are expanding their inventories of both ingredients and finished product, necessitating more storage capacity at logistics providers. DHL Life Sciences includes pharma, med devices and OTC products; recently the company also announced a 10-year relationship with Siemens Healthineeers, providers of medical imaging equipment, diagnostics and other products, for sales and service.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.